Ear, Nose & Throat (ENT)

For patients navigating chronic neurological and cardiac illness, the ears, nose, and throat are far more than incidental concerns — they are often directly implicated in the cascade of complications that follow prolonged hospitalization, neurosurgery, or systemic disease. This section explores the full spectrum of ENT and audiology conditions that arise in this patient population: from sound sensitivity disorders and intubation-induced airway scarring to the nasal consequences of repeated surgery, the sleep disruptions that follow structural changes to the airway, and the remarkable intersection between ENT medicine and skull-base neurosurgery.

Otolaryngology & Audiology: Defining the Fields

Otolaryngology — commonly known as ENT (Ear, Nose, and Throat) — is the medical and surgical specialty concerned with disorders of the head and neck, encompassing the ear, nasal cavity, sinuses, larynx (voice box), throat, trachea (windpipe), esophagus, and related structures of the skull base and neck. Otolaryngologists diagnose and treat conditions ranging from chronic sinusitis, hearing loss, and vocal cord disorders to head and neck cancers, thyroid disease, and complex airway problems.

What makes this field particularly relevant to patients with neurological illness is how frequently ENT conditions either arise from brain-related pathology or serve as the first visible sign of something deeper — a skull-base tumor pressing on cranial nerves, a pituitary adenoma causing nasal drainage, or vasogenic edema affecting the inner ear's fluid balance.

Audiology is the allied health specialty focused on the assessment, diagnosis, rehabilitation, and management of hearing, balance, and auditory processing disorders. Audiologists administer hearing evaluations, prescribe and fit hearing aids and cochlear implants, conduct vestibular testing for dizziness and balance disorders, and evaluate auditory processing in both children and adults.

In the context of neurological illness, audiologists play a critical role in identifying sensorineural hearing loss caused by ototoxic medications (such as certain chemotherapy agents, aminoglycoside antibiotics, and loop diuretics), detecting central auditory processing deficits after traumatic brain injury, and evaluating balance disorders arising from damage to the vestibular pathways. Crucially, both fields frequently uncover systemic or neurological conditions that had been previously undetected or misattributed to other causes.

Emergency Intubation: When Speed Creates Its Own Complications

When a patient collapses, stops breathing, or arrives in the emergency department in acute respiratory or cardiac failure, securing the airway is the first priority — and speed matters more than anything else. Emergency intubation performed in the field by paramedics, or in the emergency department by trauma and critical care teams, saves lives. But the urgency of the situation means that the controlled, methodical conditions of a planned surgical intubation simply do not exist. The tube may need to go in during a seizure, during active vomiting, in a patient who cannot be positioned properly, or in the chaos of a resuscitation attempt. As a result, emergency intubations carry a higher rate of airway trauma than elective intubations — and the injuries sustained in those first critical minutes can quietly shape a patient's ENT health for months or years afterward.

Several specific injuries arise with greater frequency in the emergency setting. Dental and oropharyngeal trauma — chipped or avulsed teeth, lacerations of the lips, tongue, or posterior pharynx — can occur when the laryngoscope blade is used forcefully to clear a view of the vocal cords. Esophageal intubation (placement of the tube into the esophagus rather than the trachea) is more likely under emergency conditions and, if not recognized immediately, causes rapid desaturation and hypoxic injury before the error is corrected. Arytenoid dislocation — displacement of one of the paired cartilages at the back of the larynx that anchor the vocal cords — is a recognized complication of traumatic or forceful laryngoscopy. It presents as persistent hoarseness, voice change, and airway asymmetry that does not resolve and is frequently misattributed to prolonged intubation rather than recognized as a discrete mechanical injury. Cricoarytenoid joint fixation, in which the joint becomes fibrosed and immobile following trauma, further restricts vocal cord movement and can narrow the glottic opening. Pyriform sinus perforation — a tear in the recess beside the larynx — can allow air to dissect into the neck tissues (surgical emphysema) and carries a risk of mediastinitis if unrecognized.

When a patient discharged from the ICU continues to experience hoarseness, voice changes, swallowing difficulties, or a sense of throat obstruction, a referral to otolaryngology is essential. The ENT team will typically begin with flexible nasolaryngoscopy — a thin, flexible camera passed through the nose to visualize the larynx in real time — to assess vocal cord mobility, symmetry, and any structural abnormalities. If arytenoid dislocation is identified early (within days to weeks), closed arytenoid reduction under general anesthesia can restore normal anatomy. For established cricoarytenoid joint fixation, laser arytenoidectomy (partial removal of the arytenoid cartilage) can widen the glottic airway. Swallowing function — which depends on coordinated laryngeal closure during the swallow — is assessed through modified barium swallow study or fiberoptic endoscopic evaluation of swallowing (FEES), both of which can detect silent aspiration (food or liquid entering the airway without triggering a cough reflex) — a dangerous and commonly missed complication of post-intubation laryngeal dysfunction.

Post-Intubation and Tracheal Stenosis: A Hidden Airway Crisis

Endotracheal intubation — the placement of a breathing tube through the mouth or nose into the trachea to support mechanical ventilation — is one of the most common life-saving procedures in critical care. Yet the act of intubation, and its aftermath, can generate a range of complications that fall squarely within the domain of the otolaryngologist. Pressure from the endotracheal tube against the delicate mucosal lining of the larynx and trachea can cause laryngeal granulomas — benign growths at the site of tube contact that cause persistent hoarseness, throat pain, and the sensation of a lump in the throat. Prolonged intubation can injure or stretch the recurrent laryngeal nerve, resulting in unilateral vocal cord paralysis and a weak, breathy voice that may not improve without surgical intervention. The posterior glottis — the area between the vocal cords at the back of the larynx — is particularly vulnerable to scar formation, producing posterior glottic stenosis that narrows the airway at the level of the voice box itself. Beyond the larynx, tracheostomy tubes (used when long-term airway access is needed) leave their own legacy: tracheal granulomas at the stoma site, tracheomalacia (softening and collapse of the tracheal cartilage rings), and tracheo-esophageal fistula (an abnormal connection between the airway and the food pipe, causing choking, aspiration, and recurrent pneumonia.

The ENT or otolaryngology team may be called upon to perform a range of procedures to address these complications. Flexible laryngoscopy and direct laryngoscopy allow direct visualization of the larynx and vocal cords to assess for granulomas, stenosis, or paralysis. Microlaryngoscopy with laser excision uses a CO₂ laser under microscopic visualization to remove granulomas, scar bands, or stenotic tissue within the larynx. Vocal cord medialization — either through injection laryngoplasty (injecting a material to bulk up the paralyzed cord) or open thyroplasty (repositioning the cord surgically) — restores voice quality and airway protection in patients with cord paralysis. Tracheal resection and anastomosis may be required for patients with long-segment tracheal stenosis that cannot be managed endoscopically. Throughout, the goal is to restore the airway to a safe, functional diameter while preserving as much voice and swallowing function as possible.

Endotracheal intubation — the placement of a breathing tube through the mouth or nose into the trachea to support mechanical ventilation — is a life-saving intervention in critical illness. However, prolonged intubation carries a significant and underappreciated risk: the formation of excessive scar tissue at the level of the subglottis (just below the vocal cords) or along the tracheal wall, which can progressively narrow the airway over weeks to months following extubation. This condition — subglottic or tracheal stenosis — is not rare; it is estimated to occur in 1–2% of all intubated patients, and in up to 10–11% of patients requiring prolonged intubation or tracheostomy. When the airway diameter is reduced by more than 50%, it becomes a potentially life-threatening emergency.

What makes tracheal stenosis particularly dangerous is how effectively it masquerades as other conditions. Patients — and their physicians — frequently attribute the progressive dyspnea (shortness of breath) and respiratory symptoms to asthma, deconditioning, anxiety, reactive airway disease, or cardiac insufficiency, delaying the correct diagnosis by months or even years. The cardinal symptoms of clinically significant tracheal or subglottic stenosis include: a high-pitched, musical breathing sound called stridor (most pronounced on inhalation and often audible at rest when stenosis is severe), exertional dyspnea that worsens progressively and does not respond to bronchodilators, wheezing that may be mistaken for asthma, recurrent lower respiratory infections (including pneumonia-like presentations arising from impaired clearance of secretions distal to the stenotic segment), a sensation of throat tightness or choking, and exercise intolerance that deteriorates over time without clear cardiac or pulmonary cause.

Beyond stenosis, patients who have been intubated may require additional ENT procedures in the months following discharge. Granuloma excision via microlaryngoscopy addresses benign scar nodules at the tube contact site that cause persistent hoarseness or throat discomfort. Tracheostomy decannulation — the structured process of removing a tracheostomy tube once a patient can breathe independently — requires careful ENT-supervised weaning, capping trials, and sometimes endoscopic inspection to confirm the stoma is closing properly and that no tracheomalacia or residual stenosis is present at the site.

Balloon Dilation of Subglottic Stenosis

When subglottic or tracheal stenosis is identified, the treatment approach is determined by the location, length, and severity of the narrowing. For many patients with short-segment, fibrous (non-malignant, non-inflammatory) stenosis, endoscopic balloon dilation — sometimes referred to as balloon dilation of subglottic fibrous stenosis — is the first-line intervention. Under general anesthesia, a rigid or flexible bronchoscope is advanced into the airway and a specially designed balloon catheter is positioned across the narrowed segment. The balloon is inflated to a precise diameter and pressure, mechanically widening the stenotic area by stretching or partially tearing the fibrous scar tissue. The procedure is minimally invasive, does not require external incisions, and can be repeated as the stenosis recurs — which it commonly does, as fibrous stenosis carries a high rate of re-narrowing over months to years.

In more complex or recurrent cases, balloon dilation may be combined with adjunctive treatments: intralesional steroid injection (to suppress fibroblast proliferation and slow re-scarring), topical mitomycin-C application (an antiproliferative agent that reduces scar reformation), or CO₂ laser excision of the fibrous tissue prior to dilation. For patients with long-segment stenosis, severe circumferential scarring, or failure of repeated endoscopic management, open surgical reconstruction — including cricotracheal resection with primary anastomosis or laryngotracheal reconstruction — may become necessary. The critical message for patients and families is this: if a person who has been intubated in an ICU setting develops progressive, unexplained breathing difficulty in the months following discharge, subglottic or tracheal stenosis must be actively excluded — it is treatable, but only if it is found in time.

Turbinate Surgery: Process, Purpose & Complications

The turbinates (also called nasal conchae) are three pairs of bony shelf-like structures inside the nasal cavity — the inferior, middle, and superior turbinates — covered in highly vascularized mucous membrane. Their function is essential: they warm, humidify, and filter inhaled air before it reaches the lungs, direct airflow through the nasal passages, and support mucociliary clearance (the coordinated sweeping of mucus and trapped particles toward the throat). When the inferior turbinates become chronically enlarged (turbinate hypertrophy), typically from allergic rhinitis, chronic sinusitis, or anatomical deviation, patients suffer significant nasal obstruction and impaired breathing.

Turbinate reduction surgery encompasses a range of procedures — from minimally invasive techniques (radiofrequency ablation, submucosal resection) to more extensive turbinectomy (partial or total removal of turbinate tissue). While effective for obstruction relief in appropriately selected patients, excessive turbinate removal carries its own set of serious consequences. The most significant is empty nose syndrome (ENS) — a paradoxical condition in which the nasal airway is anatomically patent (open) but the patient experiences persistent sensations of suffocation, dryness, crusting, loss of smell, and inability to perceive adequate airflow. ENS occurs because the turbinates' sensory receptors — not just their structural bulk — are responsible for the brain's perception of nasal breathing. Without sufficient turbinate tissue, the feedback loop is severed, and patients report feeling unable to breathe even with an objectively clear airway. ENS is considered iatrogenic (caused by the treatment itself) and is very difficult to reverse.

Turbinate surgery also predisposes patients to recurrent nasal and sinus infections. The turbinates generate the turbulent airflow that deposits particles on the mucosal surface for clearance; when that architecture is disrupted, pathogenic bacteria and viruses have freer access to the sinus ostia. Mucociliary transport — already impaired in many patients with chronic sinusitis — is further compromised by the loss of vascular and glandular tissue that maintains mucosal moisture. The result can be a self-perpetuating cycle: recurrent bacterial rhinosinusitis, repeated antibiotic courses, antibiotic resistance, and progressive deterioration of the remaining nasal lining.

Nasal Cartilage Removal: Infection Risk & Sleep Apnea

The nasal septum — the central dividing wall of the nose — is composed of both bone (posteriorly) and cartilage (anteriorly, in the form of the quadrangular cartilage). Septal cartilage is not merely structural scaffolding; it contributes meaningfully to the structural integrity of the nasal tip and dorsum, the patency of the internal nasal valve, and the resistance to collapse of the airway on inspiration. When cartilage is removed (septoplasty or, more extensively, submucosal resection of the septum) in amounts that exceed structural necessity, a range of downstream problems emerge.

From an infection standpoint, cartilage plays a role in maintaining the structural architecture that supports healthy mucosal flow and airway patency. Removal of cartilage — particularly when combined with prior turbinate reduction — can cause the internal nasal valve to collapse on inspiration (internal nasal valve collapse), producing turbulent airflow, impaired mucociliary transport, and areas of mucosal stasis where bacteria can establish biofilms. Biofilm formation in the post-surgical nasal cavity is a recognized mechanism for recurrent and difficult-to-treat rhinosinusitis, as the organized microbial communities embedded in polysaccharide matrices resist both the immune system and standard antibiotic courses.

With regard to sleep apnea, significant structural nasal compromise — from cartilage loss, turbinate reduction, or collapse of the internal valve — can dramatically increase nasal airway resistance during sleep. Because nasal breathing resistance determines how much negative pressure the throat must generate to draw air in, increased resistance at the nasal level promotes the collapse of the soft tissue structures of the pharynx, particularly in the lateral walls and at the level of the soft palate. This is the anatomical basis of obstructive sleep apnea (OSA). Post-surgical nasal obstruction is a recognized contributing factor to new or worsened OSA. Diagnosis is accomplished through formal overnight polysomnography (a sleep study measuring airflow, oxygen saturation, arousal index, respiratory effort, and sleep architecture) or home sleep apnea testing (HSAT) for patients without significant comorbidities. A referral to a sleep medicine specialist, often in collaboration with ENT, is the appropriate pathway.

Post-Nasal Drip After Nasal Surgery

Post-nasal drip (PND) — the sensation of mucus accumulating in or draining down the back of the throat — is one of the most persistent and frustrating symptoms reported by patients who have undergone multiple nasal or sinus surgeries. It is most noticeable overnight and upon waking, when mucus has pooled at the back of the nasopharynx during hours of recumbency, and is often accompanied by throat clearing, coughing, a sense of throat fullness, and occasionally nausea. While post-nasal drip has many causes (allergic rhinitis, acid reflux, sinonasal infection), patients who have had significant nasal surgery — especially cartilage removal, turbinate reduction, and sinus procedures — develop PND through a constellation of structural and physiological mechanisms that are often overlooked.

First, the loss of normal turbinate architecture disrupts the laminar flow of air through the nasal cavity, impairing mucociliary clearance — the mechanism by which cilia lining the nasal mucosa sweep mucus and particles toward the nasopharynx at approximately 5–10 mm/minute. When this clearance mechanism is impaired by surgical disruption of cilia-bearing epithelium, mucus pools and stagnates rather than being efficiently transported. Second, the nasal mucosa's capacity to regulate mucus volume and viscosity depends on a healthy, vascularized lamina propria — the layer of tissue just beneath the epithelium. Surgical scarring and the loss of submucosal glands reduces this regulatory capacity, leading to either excess thin mucus (watery drip) or thick, viscid secretions that are harder to clear. Third, chronic low-grade bacterial colonization of post-surgical sinus cavities — particularly in the setting of biofilm formation — produces a persistent inflammatory stimulus that drives goblet cell hyperplasia and hypersecretion.

A 2024 review in In Vivo specifically characterized chronic idiopathic post-nasal drip as a distinct clinical entity — one that is frequently underdiagnosed precisely because it does not fit neatly into existing diagnostic categories (allergic rhinitis, non-allergic rhinitis, or chronic rhinosinusitis), yet causes significant quality-of-life impairment. The authors highlight that this condition requires individualized investigation and management rather than generic rhinitis protocols.

Source: Clinical Aspects of Chronic Idiopathic Postnasal Drip: An Entity Not to Be Overlooked — In Vivo, PubMed Central 2024

A 2016 real-world study in the European Journal of Allergy and Clinical Immunology, examining outcomes in a tertiary rhinology centre, found that a significant proportion of patients who had undergone sinus surgery for chronic rhinosinusitis continued to experience uncontrolled disease post-operatively — with persistent symptoms, ongoing mucus production, and recurrent inflammation — underscoring that surgical intervention does not reliably resolve the underlying mucosal dysregulation driving hypersecretion.

Source: Real-life Study Showing Uncontrolled Rhinosinusitis after Sinus Surgery in a Tertiary Referral Centre — European Journal of Allergy & Clinical Immunology, PubMed Central 2016

When advanced imaging — typically a contrast-enhanced MRI or CT scan — identifies a mass at or near the skull base, the next step is almost never a solo decision. These lesions sit at the crossroads of multiple specialties, and the path from "something is there" to "we know what it is and how to treat it" almost always requires ENT and neurosurgery to work together from the very beginning. The ENT surgeon's contribution begins before the patient ever reaches the operating room: a thorough nasal endoscopy maps the patient's existing sinonasal anatomy, identifying septal deviations, scarring from prior surgeries, polyps, or other anatomical constraints that will affect how safely and efficiently the surgical corridor can be established.

For patients who have already had multiple nasal procedures, this pre-operative assessment is particularly critical — what looks straightforward on imaging may be considerably more complex when the nasal passages have been altered by previous operations. At the same time, the neurosurgical team reviews the imaging in detail to characterize the lesion: its precise location, its relationship to critical neurovascular structures (carotid arteries, optic nerves, cavernous sinuses, cranial nerve foramina), its signal characteristics on MRI (which can suggest the likely tissue type), and whether it is enhancing with contrast (suggesting vascularity or active blood–brain barrier disruption).

This joint pre-operative planning — often formalized through a multidisciplinary skull base tumor board that may also include neuroradiology, neuro-oncology, endocrinology, and radiation oncology — determines whether the mass can be safely reached through the nose, and whether the goal is biopsy only, partial resection, or complete removal.

The ENT–Neurosurgery Intersection: Skull-Base Tumors & the Nasal Corridor

One of the most remarkable intersections of ENT medicine and neurosurgery involves tumors at the skull base — specifically those arising in or around the sellar, suprasellar, and parasellar regions. The sella turcica is the bony saddle at the base of the skull that houses the pituitary gland; the suprasellar space above it contains the optic chiasm, hypothalamus, and anterior communicating artery complex; and the parasellar spaces on either side encompass the cavernous sinuses, which carry the carotid arteries and multiple cranial nerves. Tumors in these regions — including pituitary adenomas, craniopharyngiomas, meningiomas, Rathke's cleft cysts, and, in younger patients, juvenile pilocytic astrocytomas (JPA) arising from the hypothalamus or optic chiasm — present with a unique combination of endocrine dysfunction, visual field deficits, and headache, but may also cause nasal symptoms when they extend inferiorly toward the sphenoid sinus.

The standard surgical approach for biopsy or resection of these lesions is the endoscopic endonasal transsphenoidal approach — a procedure performed entirely through the nostrils. Working jointly, an ENT surgeon and a neurosurgeon navigate an endoscope through the nasal cavity, through the sphenoid sinus (which sits immediately in front of the sella), and into the sellar or suprasellar space to access the tumor. No external incisions are made; the entire surgical corridor runs through the patient's own nose and sinuses. For a patient who has had prior nasal surgeries — turbinate reduction, septoplasty, or sinus procedures — this surgical corridor may be significantly altered, creating additional complexity for the surgical team and increased risk of post-operative sinonasal complications including scarring, post-nasal drip, and nasal crusting.

The Mayo Clinic provides a detailed overview of transsphenoidal surgery — including how the procedure is performed, what patients can expect during recovery, and the role of the ENT-neurosurgery team — that is an excellent starting point for patients or families facing this type of procedure.

Sources: Transsphenoidal Surgery — Mayo Clinic · Sellar, Suprasellar, and Parasellar Masses: Imaging Features and Neurosurgical Approaches — PubMed

Sound Tolerance Disorders: Misophonia & Hyperacusis

Both misophonia and hyperacusis are classified as sound-tolerance disorders of the auditory system and are generally managed under the combined care of otolaryngology (ENT) and audiology, often with input from neuropsychology when the emotional and autonomic responses are particularly pronounced.

Hyperacusis is a condition in which ordinary environmental sounds — conversation, cutlery on a plate, traffic, a television — are perceived as painfully, distressingly, or uncomfortably loud, well beyond what the actual decibel level would justify. It affects approximately 1 in 50,000 people in the general population but is significantly more prevalent among those with neurological conditions, chronic illness, and a history of head injury or prolonged ICU care. Hyperacusis is thought to arise from maladaptive neuroplasticity in the central auditory system — the brain's gain control is turned too high, amplifying incoming sound signals beyond their true intensity. It is frequently comorbid with tinnitus.

Management approaches include sound therapy (gradual desensitization using broadband noise at low levels), hearing protection counseling (paradoxically, overprotection can worsen the condition by deepening the brain's sensitivity), cognitive-behavioral therapy (CBT), and in some cases tinnitus retraining therapy (TRT).

Misophonia — literally "hatred of sound" — is distinct from hyperacusis in that the distress is not about volume but about specific trigger sounds: chewing, breathing, typing, tapping, or other repetitive auditory cues. The reaction is not merely annoyance but an intense, involuntary emotional and physiological response — rage, panic, disgust, or the urge to flee — that is disproportionate to the trigger and deeply disruptive to daily functioning. Misophonia is thought to involve aberrant connectivity between the auditory cortex and the limbic system and anterior insula, meaning the brain is routing certain sounds directly through emotional threat-response pathways. It is increasingly recognized in patients with TBI, PTSD, autism spectrum disorder, and obsessive-compulsive spectrum conditions.

There is no FDA-approved pharmacological treatment; current management relies on sound-masking strategies, CBT, tinnitus retraining therapy, and the establishment of structured environmental controls. A 2024 retrospective study published in the International Journal of Pediatric Otorhinolaryngology examined how hyperacusis and misophonia co-occur in children with Auditory Processing Disorder (APD) — a condition in which auditory signals are not efficiently processed despite normal hearing sensitivity. The study found that while both conditions are prevalent in this population, they present with distinguishable clinical profiles: hyperacusis reflects abnormal loudness tolerance driven by central auditory gain dysregulation, while misophonia manifests as pattern-specific emotional and autonomic reactivity to particular trigger sounds. This distinction matters clinically because desensitization protocols appropriate for hyperacusis can be counterproductive in misophonia, and correct identification of which condition — or combination — is present is essential for targeted intervention.

The Neurophysiological Model: Subcortical, Limbic & Autonomic Connections

The most clinically rigorous framework for understanding hyperacusis and misophonia comes from the work of Dr. Pawel Jastreboff and Margaret Jastreboff, whose neurophysiological model — developed over decades of research — fundamentally reframes both conditions. Rather than treating them as disorders of the ear or the auditory cortex alone, the model identifies the core dysfunction as abnormal connections between the auditory system and the subcortical, limbic, and autonomic nervous systems: the networks governing emotion, survival responses, and involuntary bodily function. The model introduced the umbrella term Decreased Sound Tolerance (DST) to encompass all conditions in which a person's response to sound is significantly more negative than the sound's physical properties would predict. DST includes hyperacusis (abnormal loudness sensitivity), misophonia (conditioned pattern-specific emotional reactivity), and phonophobia (fear of specific sounds based on anticipated harm). These are distinct conditions — but they can co-occur in the same patient, and accurate differentiation is essential before treatment can be appropriately targeted.

In people without DST, sounds are processed through the auditory cortex and evaluated for significance before any emotional or autonomic response is generated. In individuals with hyperacusis or misophonia, this gating function breaks down. In hyperacusis, the central auditory system's gain control is dysregulated — all incoming signals are amplified beyond their true intensity, making ordinary environmental sounds painful or distressing regardless of their pattern or source. The emotional response is secondary: discomfort and protective behaviors arise as a consequence of the perceived loudness. In misophonia, auditory gain is generally normal — the trigger sounds are not perceived as louder than they are — but a conditioned reflex arc has formed between specific auditory patterns and the limbic system and autonomic nervous system. Incoming trigger sounds (chewing, breathing, typing, tapping) are shunted through the amygdala and associated limbic structures, generating immediate autonomic activation — heart rate increase, cortisol release, muscle tension, the fight-or-flight cascade — with almost no cognitive mediation. The brain has established a subcortical "fast track" that bypasses rational evaluation and produces a survival-level response to a non-threatening stimulus. This is why misophonia sufferers cannot simply choose not to react: the physiological cascade is occurring below the threshold of conscious control.

Another key distinction is scope. Hyperacusis tends to be generalized — many or all sounds above a relatively low threshold will trigger it — while misophonia is highly specific: particular auditory patterns elicit the response while other sounds of similar or greater volume do not. Over time, misophonia can broaden: the trigger may extend from the sound itself to the visual anticipation of the sound (watching someone reach for a bag of chips, for instance), and secondary triggers may develop around contexts where primary triggers have previously been encountered. Both conditions can cause significant avoidance — but for different reasons. Hyperacusis avoidance is driven by the need to protect against painful loudness; misophonia avoidance is driven by the need to escape the emotional-autonomic cascade. Understanding this distinction matters because the therapeutic approaches diverge significantly, and a treatment that is helpful for one condition can be counterproductive for the other.

Can Seizures Cause Decreased Sound Tolerance?

There is emerging clinical evidence — and significant neurological plausibility — that seizure activity can generate or exacerbate DST. The auditory cortex and the superior temporal gyrus are among the most common sites of seizure onset in temporal lobe epilepsy. During a seizure, aberrant neuronal firing in these regions can produce auditory experiences — hallucinations, distortions, or intense sound sensitivity — as ictal phenomena: symptoms occurring during the seizure itself as a direct manifestation of the abnormal electrical discharge. Misophonia-like and hyperacusis-like symptoms have been documented as ictal events in the literature on temporal lobe seizures, occurring as part of the seizure's sensory aura or as a primary ictal expression.

Post-ictally — in the hours or days following a seizure — some patients experience prolonged sound sensitivity that outlasts the episode itself. This is consistent with the neurophysiological model's core claim: repeated aberrant firing in the auditory-limbic interface may establish or reinforce maladaptive reflex arcs, essentially "training" the subcortical pathways toward heightened reactivity in the same way that conditioned learning embeds behavioral responses. For patients with neurological illness that includes a seizure history, any newly emerging or worsening sound intolerance should prompt discussion with the neurology team — particularly if the pattern of symptoms corresponds to seizure timing. The interplay between epilepsy, auditory processing, and DST remains an area where research is active.

Cognitive Impact of Decreased Sound Tolerance

The cognitive burden of DST extends well beyond the moment of sound exposure. Hypervigilance — constant scanning of the environment for threatening sounds — consumes significant attentional and working memory resources, leaving less cognitive bandwidth available for information processing, learning, and executive function. In severe hyperacusis, patients may restrict their environments to the point of near-total withdrawal from social, professional, and educational life, creating compounding consequences for mental health, identity, and long-term neurological function. In misophonia, the anticipatory anxiety that precedes potential sound exposure can be as debilitating as the response itself: patients may spend hours planning avoidance strategies, rehearsing exit plans, or mentally bracing for triggers — a state of chronic cognitive load that is exhausting and cognitively depleting.

Chronic autonomic activation associated with DST compounds cognitive difficulties through multiple pathways: sustained cortisol elevation impairs hippocampal function and memory consolidation; sleep disruption (a near-universal consequence of DST) degrades neuroplastic recovery overnight; and repeated exposure to the emotional-autonomic cascade reinforces the conditioned reflex arc, making it progressively more entrenched over time. The longer DST goes unrecognized and untreated, the more the subcortical pathways are reinforced — and the more deeply the condition becomes embedded in the patient's behavioral, cognitive, and physiological architecture. This does not mean recovery is impossible, but it does mean that early identification and intervention are critical.

Treatment: Sound Generators, Habituation & Building New Associations

The neurophysiological model is explicitly hopeful: because the pathological reflex arcs in DST are conditioned, they can, in principle, be reconditioned through structured, sustained intervention. The Jastreboff approach to treatment — often called Tinnitus Retraining Therapy (TRT) when applied to tinnitus, and extended to DST more broadly — has two core components working in concert: sound therapy using wearable sound generators, and directive counseling to reshape the patient's cognitive and emotional associations with sound.

Sound generators are wearable devices — worn like hearing aids — that deliver a continuous, low-level broadband noise to the ear throughout the day. The goal is not masking (drowning out trigger sounds or tinnitus) but habituation: by consistently pairing the auditory environment with a steady, neutral, non-threatening signal, the devices create the neurological conditions for the limbic and autonomic systems to begin recalibrating their response. Over weeks and months, the subcortical "fast track" gradually loses urgency as the brain accumulates consistent evidence that the auditory environment is safe and manageable. The level of the broadband noise is set below the patient's discomfort threshold and adjusted carefully over time — overuse or too-high levels can worsen sensitivity rather than improve it, so the titration process is managed with the clinician.

Alongside sound generators, the directive counseling component works with the patient to build deliberate cognitive-emotional associations around sounds. Clinicians trained in the neurophysiological approach help patients identify the narratives, beliefs, and predictions that have become attached to trigger sounds — the interpretations that reinforce the brain's classification of certain sounds as threats. Through structured sessions, patients challenge catastrophic interpretations, practice observing trigger sounds from a position of reduced reactivity, and gradually reintroduce avoided sounds in controlled, intentional settings where the emotional stakes are deliberately lowered. This process is analogous to graduated exposure used in trauma therapy, but it is specifically designed around the auditory-limbic model — it is not generic CBT, and it works best when clinicians understand the distinction between hyperacusis and misophonia and calibrate the approach accordingly.

Progress is rarely linear, and patients who have spent years in avoidance — with deeply reinforced subcortical pathways — typically require longer treatment timelines and more frequent recalibration of the sound generator level and counseling approach. However, functional improvement is achievable in the majority of patients across the DST spectrum, and complete or near-complete habituation is reported in a significant subset. The neurophysiological model's consistent finding is that recovery is possible but time-sensitive: the earlier the intervention, the less entrenched the conditioned pathways, and the more effectively the brain can generate new, neutral associations to replace the maladaptive ones.

Sources: Decreased Sound Tolerance: Hyperacusis, Misophonia, Diplacousis, and Polyacousis — Jastreboff & Jastreboff, Handbook of Clinical Neurology, 2015 · Treatments for Decreased Sound Tolerance (Hyperacusis and Misophonia) — Jastreboff & Jastreboff, Seminars in Hearing, 2014 · The Neurophysiological Approach to Misophonia: Theory and Treatment — Jastreboff & Jastreboff · The Neurophysiological Model for Hyperacusis and Misophonia — Jastreboff & Jastreboff · Diagnosis and Treatment of Misophonia and Hyperacusis based on the Neurophysiological Model — Jastreboff & Jastreboff

Research & Additional References